livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirus-infecties - antivirale middelen voor systemisch gebruik - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). aandacht moet worden gegeven aan de officiële richtlijnen betreffende het juiste gebruik van antivirale middelen.
darunavir sandoz 400 mg filmomh. tabl.
sandoz sa-nv - darunavir 400 mg - filmomhulde tablet - 400 mg - darunavir 400 mg - darunavir
darunavir eg 400 mg filmomh. tabl.
eg sa-nv - darunavir 400 mg - filmomhulde tablet - 400 mg - darunavir 400 mg - darunavir
darunavir eg 800 mg filmomh. tabl.
eg sa-nv - darunavir 800 mg - filmomhulde tablet - 800 mg - darunavir 800 mg - darunavir
darunavir sandoz 800 mg filmomh. tabl.
sandoz sa-nv - darunavir 800 mg - filmomhulde tablet - 800 mg - darunavir 800 mg - darunavir
darunavir eg 75 mg filmomh. tabl.
eg sa-nv - darunavir 75 mg - filmomhulde tablet - 75 mg - darunavir 75 mg - darunavir
darunavir eg 150 mg filmomh. tabl.
eg sa-nv - darunavir 150 mg - filmomhulde tablet - 150 mg - darunavir 150 mg - darunavir
darunavir eg 300 mg filmomh. tabl.
eg sa-nv - darunavir 300 mg - filmomhulde tablet - 300 mg - darunavir 300 mg - darunavir
darunavir eg 600 mg filmomh. tabl.
eg sa-nv - darunavir 600 mg - filmomhulde tablet - 600 mg - darunavir 600 mg - darunavir
darunavir sandoz 150 mg filmomh. tabl.
sandoz sa-nv - darunavir 150 mg - filmomhulde tablet - 150 mg - darunavir 150 mg - darunavir